Webinar
Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-FGFR2, BAY 1187982 Vector   (CAT#: GTVCR-WQ617MR)

This product GTVCR-WQ617MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting FGFR2. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_000141.5
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 2263
UniProt ID P21802
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-FGFR2, BAY 1187982 Vector (GTVCR-WQ617MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ702MR IVTScrip™ pSP6-VEE-mRNA-Anti-PDCD1, BI-754091 Vector Vector BI-754091
GTVCR-WQ1294MR IVTScrip™ pSP6-VEE-mRNA-Anti-ERBB2, GEXMab73 Vector Vector GEXMab73
GTVCR-WQ2664MR IVTScrip™ pT7-VEE-mRNA-Anti-Felcat NGF, ZTS-00084768 Vector Vector ZTS-00084768
GTVCR-WQ2513MR IVTScrip™ pSP6-VEE-mRNA-Anti-CSF1R, SNDX-6352 Vector Vector SNDX-6352
GTVCR-WQ2211MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFRSF9, PF-05082566 Vector Vector PF-05082566
GTVCR-WQ385MR IVTScrip™ pSP6-VEE-mRNA-Anti-F, ALX-0171 Vector Vector ALX-0171
GTVCR-WQ2625MR IVTScrip™ pSP6-VEE-mRNA-Anti-VEGFA, VEGF Trap Vector Vector VEGF Trap
GTVCR-WQ462MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD19&CD3E, AMG103 Vector Vector AMG103
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.